Found: 17
Select item for more details and to access through your institution.
In vivo and in vitro antitumor activity of oxaliplatin in combination with cetuximab in human colorectal tumor cell lines expressing different level of EGFR.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 57, n. 6, p. 709, doi. 10.1007/s00280-005-0123-3
- By:
- Publication type:
- Article
4,4′-Dihydroxybenzophenone-2,4-dinitrophenylhydrazone (A-007): a topical treatment for cutaneous metastases from malignant cancers.
- Published in:
- 2006
- By:
- Publication type:
- Editorial
Phase I dose-finding study and a pharmacokinetic/pharmacodynamic analysis of the neutropenic response of intravenous diflomotecan in patients with advanced malignant tumours.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 57, n. 6, p. 727, doi. 10.1007/s00280-005-0112-6
- By:
- Publication type:
- Article
A phase I combination chemotherapy study of biweekly paclitaxel and S-1 administration in patients with advanced gastric cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 57, n. 6, p. 736, doi. 10.1007/s00280-005-0122-4
- By:
- Publication type:
- Article
Inhibition of cytokinesis and akt phosphorylation by chaetoglobosin K in ras-transformed epithelial cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 57, n. 6, p. 741, doi. 10.1007/s00280-005-0113-5
- By:
- Publication type:
- Article
A phase I study of 3-day topotecan and cisplatin in elderly patients with small-cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 57, n. 6, p. 755, doi. 10.1007/s00280-005-0117-1
- By:
- Publication type:
- Article
Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastases
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 57, n. 6, p. 761, doi. 10.1007/s00280-005-0120-6
- By:
- Publication type:
- Article
Long intracellular retention of 4′-thio-arabinofuranosylcytosine 5′-triphosphate as a critical factor for the anti-solid tumor activity of 4′-thio-arabinofuranosylcytosine.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 57, n. 6, p. 772, doi. 10.1007/s00280-005-0126-0
- By:
- Publication type:
- Article
Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transporters.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 57, n. 6, p. 781, doi. 10.1007/s00280-005-0121-5
- By:
- Publication type:
- Article
A phase I clinical trial of 12- O-tetradecanoylphorbol-13-acetate for patients with relapsed/refractory malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 57, n. 6, p. 789, doi. 10.1007/s00280-005-0125-1
- By:
- Publication type:
- Article
Second-line chemotherapy in small cell lung cancer in a modified administration of topotecan combined with paclitaxel: a phase II study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 57, n. 6, p. 796, doi. 10.1007/s00280-005-0085-5
- By:
- Publication type:
- Article
The effect of cytostatic drug treatment on intestine-specific transcription factors Cdx2, GATA-4 and HNF-1alpha in mice.
- Published in:
- 2006
- By:
- Publication type:
- journal article
In vivo antitumor efficacy and cardiotoxicity of novel anthracycline ID6105 (11-hydroxy-aclacinomycin X, Hyrubicin).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 57, n. 6, p. 811, doi. 10.1007/s00280-005-0118-0
- By:
- Publication type:
- Article
The effect of P-glycoprotein and cytochrome P450 3a on the oral bioavailability of vinorelbine in mice.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 57, n. 6, p. 819, doi. 10.1007/s00280-005-0088-2
- By:
- Publication type:
- Article
Pharmacodynamic properties of methotrexate and Aminotrexate<sup>TM</sup> during weekly therapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 57, n. 6, p. 826, doi. 10.1007/s00280-005-0115-3
- By:
- Publication type:
- Article
Methylenetetrahydrofolate reductase gene polymorphisms: genomic predictors of clinical response to fluoropyrimidine-based chemotherapy?
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 57, n. 6, p. 835, doi. 10.1007/s00280-005-0089-1
- By:
- Publication type:
- Article
ACKNOWLEDGEMENT TO REVIEWERS.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 57, n. 6, p. 841, doi. 10.1007/s00280-006-0194-9
- Publication type:
- Article